USA Informational Links

National Informational Links

CDC Publications Link 

2024 – National Substance Use and Mental Health Services Survey (N-SUMHSS) 2023: Data on Substance Use and Mental Health Treatment Facilities

2024 – Model Overdose Reversal Agents Act (LAPPA Oct 2024)

2024 – Preventing Substance Use Among Young Adults with Disabilities (Aug 2024)

2024 – Model Access to Medication for Addiction Treatment in Correctional Settings Act (LAPPA Sept 2024)

2024 – Overcoming Stigma Related to Substance Use and Mental Health in Tribal Communities (COSSUP Aug 2024)

2024 – Spreading the Word About COSSUP Court Navigation Programs

2024 – Building a Safer Workforce: Addressing Opioid Use Disorder in High-risk Industries (COSSUP)

2024 – Prescription Drug Monitoring Program Highlights for August 2024 (COSSUP)

2024 – Rural Responses to the Opioid Epidemic – Impact Report (COSSUP)

2024 – Legal Mapping of Overdose Fatality Review Committees and Prescription Drug Monitoring Programs (Astho 2024)

2024 – Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (SAMHSA)

2024 – National Drug Threat Assessment (DEA 2024)

2024 – Novel Psychoactive Substances: Xylazine – Update (LAPPA – March 2024)

2024 – Online Health and Safety for Children and Youth: Best Practices for Families and Guidance for Industry (SAMSHA)

2024 – Deflection Centers: A Public Health Approach to Public Safety (COSSUP)

2024 – Building Bridges Initiative Mobilizes Public Health and Public Safety Teams to Increase Access to Opioid Treatment in Jails (COSSUP)

2024 – National Forum Shows Overdose Fatality Review Community of Practice Growing, Influence and Impact Widening (COSSUP)

2024 – Mitigating Risks from Human Xylazine Exposure

2024 – There’s a Crisis, Call a Peer: How People with Lived Experience Make Mental Health Crisis Services More Effective

2024 – Fentanyl Screening in Hospitals (LAPPA)

2024 – Prevention With Purpose: A Strategic Planning Guide for Preventing Drug Misuse Among College Students

2024 – Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA (Perspective Paper)

2023 – Developmental implications of prenatal opioid exposure among school-aged children: a mixed methods and community-initiated analysis

2023 – Implementing Best Practices Across the Continuum of Care to Prevent Overdose – A Roadmap for Governor’s

2023 – CATO Briefing Paper: Overdose Prevention Centers

2023 – The Legislative Primer Series for Front-End Justice Deflection and Diversion Report (NCSL)

2023 – Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021 (CDC)

2023 – Model School Response to Drugs and Drug-Related Incidents Act (LAPPA – May 2023)

2023 – The National Institute on Drugs and Addiction – Congressional Justification FY-2023

2023 – DAWN: Non-Fatal Overdoses Short Report

2023 – Policy Priority Roundtable Summary Report (SAMHSA)

2023 – Virtual Town Hall: Expanding Buprenorphine Access in Pharmacies to Treat Opioid Use Disorder (SAMHSA/DEA)

2023 – More Than 1 in 9 People With Co-Occurring Mental Illness and Substance Use Disorders Are Arrested Annually (PEW)

2023 – Highlights for the 2021 National survey on Drug Use and Health

2023 – Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health

2023 – Best Practice Guidance for Post-Overdose Outreach

2022 – States Should Measure Opioid Use Disorder Treatment to Improve Outcomes (PEW)

2022 – NALOXONE – Vending Machine Implementation Report

2022 – Drug Abuse Warning Network (DAWN): Findings from Drug-Related Emergency Department Visits, 2021

2022 – Public Health and Safety Team (PHAST) Toolkit (CDC)

2022 – Basic Drug Use Epidemiology – A Guide (CDC)

2022 – FROM CRISIS TO CARE – Building from 988 and Beyond for Better Mental Health Outcomes (NASMHPD)

2022 – Opioid Overdoses and the Limited Treatment of Opioid Use Disorder Continue To Be Concerns for Medicare Beneficiaries (OIG)

2022 – Community Engagement: An Essential Component of an Effective and Equitable Substance Use Prevention System (SAMHSA)

2022 – Fatal and non-fatal opioid overdose-related 911 EMS dispatches January 2022- August 2022 (N-DEWS)

2022 – Issue brief: Nation’s drug-related overdose and death epidemic continues to worsen (AMA Sept 2022)

2022 – Modeling the evolution of the US opioid crisis for national policy development

2022 – Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis 

2022 – 2021 Monitoring the Future Panel Study Annual Report – National data on substance use among adults ages 19 to 60, 1976-2021

2022 – Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study (Lancet Public Health 2022)

2022 – Engaging Parents and Youths with Lived Experience: Strengthening Collaborative Policy and Practice Initiatives for Families with Mental Health and Substance Use Disorders (NCSACW)

2022 – National Institutes of Health (NIH) – Overdose Prevention Centers (OPC)

2022 – Law enforcement seizures of pills containing fentanyl increased dramatically between 2018-2021 (NIH)

2022 – Drug Take-Back and Disposal Programs: Summary of State Laws

2022 – A Panel Study of the Effect of Cannabis Use on Mental Health, Depression and Suicide in the 50 States

2022 – Canada-U.S. Joint White Paper: Substance Use and Harms during Covid-19 Pandemic and Approaches to Federal Surveillance and Response

2022 – United Nations Office on Drugs and Crime (UNDOC) – World Drug Report 2022

2022 – Telehealth and Substance Use Disorder Services in the Era of Covid 19: Review and Recommendations

2022 – European Drug Report – Trends and Developments

2022 – A Guide to DEA Narcotic Treatment Program Regulations

2022 – Managing Substance Withdrawal in Jails: A Legal Brief (BJA 2022)

2022 – Overdose Fatality Review – Fact Sheet (LAPPA)

2022 – WHO Expert Committee on Drug Dependance

2022 – Commission on Combating Opioid Trafficking: Final Report

2022 – Standardizing the Clinical Definition of Opioid Withdrawal in the Neonate

2022 – Primer on Spending Funds from the Opioid Litigation – A guide for State and Local Decision Makers

2022 – AMA – State Toolkit to End the Nation’s Drug Overdose Epidemic

2021 – Creating Reach Beyond the Jail Walls: An Implementation Guide for Harm Reduction Re-Entry Wrap Around Services Programs

2021 – Medication-Assisted Treatment in the Courtroom – A Benchcard for Judicial Professionals Serving Parents and Children by Opioid Use Disorders (NCSACW)

2021 – Model Law Enforcement and Other First Responder Deflection Act (LAPPA)

2021 – Model Syringe Services Program Act (LAPPA)

2021 – Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders (SAMHSA)

2021 – Treatment Considerations for Youth and Young Adults with Serious Emotional Disturbances/Serious Mental Illnesses and Co-occurring Substance Use (SAMHSA)

2021 – Report of the National Survey to Assess First Responder Deflection Programs in Response to the Opioid Crisis – Final Report

2021 – AMA Report – Physicians’ actions to help end the nation’s drug-related overdose and death epidemic —and what still needs to be done

2021 – Using Taxes to Fight the Opioid Epidemic (Article)

2021 – State-Level Economic Costs of Opioid Use Disorder and Fatal Opioid Overdose — United States, 2017 (CDC)

2021 – Drug Misuse: Most States Have Good Samaritan Laws and Research Indicates They May Have Positive Effects (GAO Report)

2021 – Medical Use of CANNABIDIOL (CBD) in Older Adults: A focused Discussion on Safety

2020 – Indian Health Services – Medication Assisted Treatment Using Tele-MAT 

2020 – Drugs, Brains, and Behavior: The Science of Addiction (NIH)

2020 – Evidence Based Strategies for Abatement of Harms from the Opioid Epidemic

2020 – Reducing barriers and getting creative – 10 federal options to increase treatment access for opioid use disorder and reduce fatal overdoses (Brookings)

2020 – Policy Changes Could Bolster Prescription Drug Monitoring Programs (PEW Charitable Trust)

2020 – Impact: A Socio-Economic Review of Supervised Consumption Sites in Alberta (Alberta Health)

2020 – Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis (AJPH Open-Themed Research)

2020 – Ownership—But Not Physical Movement—of Selected Drugs Can Be Traced Through the Supply Chain (OIG/HHS)

2020 – National Interdiction Command and Control Plan (ONDCP)

2020 – National Drug Control Strategy – Office of National Drug Control Policy

2020 – GAO Report – Drug Control – Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders

2019 – The Economic Cost of the Opioid Crisis in the U.S.: A State-by-State Comparison – Policy Brief (MHA)

2019 – Review of the Drug Enforcement Administration’s Regulatory and Enforcement Efforts to Control the Diversion of Opioids (OIG/DOJ)

2019 – Summary and Impact Analysis of State Laws Addressing Predatory and Unethical Substance Use Disorder Treatment Practices (NAMSDL)

2018 – Evidence-Based Strategies for Preventing Opioid Overdose: What’s Working in the United States (CDC)

2018 – American Medical Association Opioid Task Force 2018 Progress Report

2018 – AMA Fact Sheet: PDMP use increases from 61M to more than 300M from 2014-2017 

2018 – Self Compliance Tool for the Mental Health Parity and Addiction Equity Act (MHPAEA)

2017 – Fentanyl Briefing Guide for First Responders

2017 – Trends in Substance Use Disorders Among Adults Aged 18 or Older – The CBHSQ Report

2017 – Inventory of HHS Research on Pain and Opioid Misuse and Overdose

2017 – Prescription Opioid Exposures Among Children and Adolescents in the United States: 2000–2015

2017 – International Narcotics Control Strategy Report (INCSR) – Volume I: Drug and Chemical Control 

2016 – SAMHSA – Facing Addiction in America – The Surgeon General’s Spotlight on Opioids

2016 – SAMHSA – Facing Addiction in America – The Surgeon General’s Report on Alcohol, Drug, and Health

2016 – Medication-Assisted Treatment Improves Outcomes for Patients With Opioid Use Disorder

2016 – National Drug Threat Assessment Summary (US DOJ DEA)

2016 – United Nations Office on Drugs and Crime – World Drug Report

2016 – Opioid Overdose Prevention Toolkit (SAMSHA)

2016 – The Opioid Epidemic by the Numbers – HHS Fact Sheet

2016 – HHS Opioid Research Portfolio Brief – Translating Science into Action – Research Portfolio Brief

2016 – HHS Research on Pain Treatment and Opioid Misuse and Overdose – Translating Science Into Action – Infographic

2016 – 2015 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 33rd Annual Report

2016 – Decisions in Dentistry – Taking on Prescription Opioid Abuse

2016 – National Safety Council – Prescription Nation 2016 – Addressing America’s Drug Epidemic

2016 – PDMP-TTAC Technical Assistance Guide – Prescriber Report Cards

2016 – CDC Morbidity and Mortality Weekly Report – Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014

2016 – Coverage of Substance-Use Disorder Treatments in Marketplace Plans in Six Cities

Last updated on 10/17/2024

Please report any broken links to tech@naddi.org

Copyright © 2025 - NADDI. All Rights Reserved.

Disclaimer / Privacy Policy / Copyright Policy

Log in with your credentials

Forgot your details?